KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Current Taxes (2016 - 2025)

Gsk (GSK) has 8 years of Current Taxes data on record, last reported at $902.3 million in Q4 2024.

  • For Q4 2024, Current Taxes rose 45.4% year-over-year to $902.3 million; the TTM value through Dec 2024 reached $902.3 million, up 45.4%, while the annual FY2024 figure was $898.6 million, 44.49% up from the prior year.
  • Current Taxes reached $902.3 million in Q4 2024 per GSK's latest filing, up from $620.6 million in the prior quarter.
  • Across five years, Current Taxes topped out at $902.3 million in Q4 2024 and bottomed at $552.4 million in Q4 2022.
  • Average Current Taxes over 4 years is $683.6 million, with a median of $639.9 million recorded in 2023.
  • Peak YoY movement for Current Taxes: decreased 16.19% in 2022, then skyrocketed 45.4% in 2024.
  • A 4-year view of Current Taxes shows it stood at $659.2 million in 2021, then fell by 16.19% to $552.4 million in 2022, then grew by 12.33% to $620.6 million in 2023, then soared by 45.4% to $902.3 million in 2024.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $902.3 million in Q4 2024, $620.6 million in Q4 2023, and $552.4 million in Q4 2022.